{"result": "(\"entity\"<|>CVC<|>ORGANIZATION<|>CVC refers to Central Venous Catheters, which are used for long-term access to the vascular system for patients requiring intravenous therapy.)\n##\n(\"entity\"<|>PSEUDOMONA AERUGINOSA<|>ORGANIZATION<|>Pseudomonas aeruginosa is a type of gram-negative bacteria that can cause infections, particularly in patients with compromised immune systems.)\n##\n(\"entity\"<|>NUTRICIÓN PEDIÁTRICA<|>EVENT<|>Nutrición Pediátrica refers to pediatric nutrition, which is a field of medicine focused on the dietary needs and nutritional health of children.)\n##\n(\"entity\"<|>TAUROLIDINA<|>ORGANIZATION<|>Taurolidine is a compound used in medical treatments, particularly for preventing infections associated with catheters.)\n##\n(\"entity\"<|>ALCOHOL AL 70%<|>ORGANIZATION<|>70% alcohol is commonly used as a disinfectant in medical settings to maintain aseptic techniques.)\n##\n(\"relationship\"<|>CVC<|>NUTRICIÓN PEDIÁTRICA<|>CVCs are often used in pediatric nutrition for patients requiring long-term intravenous feeding<|>7)\n##\n(\"relationship\"<|>PSEUDOMONA AERUGINOSA<|>CVC<|>Pseudomonas aeruginosa is a common pathogen associated with infections in patients with CVCs<|>8)\n##\n(\"relationship\"<|>TAUROLIDINA<|>CVC<|>Taurolidine is used as a prophylactic treatment to prevent infections in patients with CVCs<|>6)\n##\n(\"relationship\"<|>ALCOHOL AL 70%<|>CVC<|>70% alcohol is used to maintain aseptic techniques in the handling of CVCs<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ación de la solución infundida. Las dos principales puertas de infección son el punto de inserción en la piel (en los catéteres de corta duración) y el cabezal o extremo del catéter (en los catéteres permanentes). Además, puede haber infecciones en el punto de inserción en la piel o, en el caso de los catéteres tunelizados, en el trayecto subcutáneo71.\n\nLa retirada del catéter ha sido considerada tradicionalmente el tratamiento de elección y, salvo que existan problemas de accesos vasculares, lo sigue siendo en los catéteres de corta duración. En los CVC de larga duración, las indicaciones de retirada son: infecciones fúngicas documentadas, bacteriemias recurrentes, tunelitis, persistencia de fiebre más de 48 horas después de iniciado el tratamiento antibiótico y las infecciones polimicrobianas71. Las estrategias terapéuticas y la antibioterapia se recogen en la tabla 12. Aunque el germen más frecuentemente implicado en las BC es el estafilococo coagulasa negativo, la terapia antibiótica empírica debe cubrir también bacilos gramnegativos, incluida Pseudomona aeruginosa. Una vez conocido el resultado del hemocultivo y del antibiograma se modificará la pauta antibiótica. La duración del tratamiento dependerá del germen aislado, pero en general no será inferior a 10-14 días si no se retira el catéter. Si se trata de un estafilococo coagulasa negativo y se retira el catéter es suficiente un ciclo de 5 a 7 días. En catéteres de larga duración\n---\n874      BLOQUE: NUTRICIÓN PEDIÁTRICA\n\nTabla 12. Estrategias de tratamiento de las infecciones asociadas a catéter.\n\n| Infección | Manifestaciones | Tratamiento |\n|-----------|-----------------|-------------|\n| Punto de inserción | · Eritema, induración o exudado a < 2 cm del orificio de salida | · Tratamiento tópico<br>· Antibióticos orales |\n| Trayecto tunelizado | · Eritema, induración o exudado a > 2 cm del orificio de salida | · Retirada del catéter<br>· Antibióticos sistémicos (?) |\n| Localización del reservorio | · Eritema o necrosis o exudado en la piel sobre el reservorio | · Retirada del reservorio<br>· Antibióticos sistémicos |\n| Bacteriemia asociada a catéter | · Hemocultivo positivo del catéter y vía periférica<br>+<br>· No otro origen de la fiebre<br>o<br>· Desaparición de la fiebre tras la retirada del catéter | · Antibióticos sistémicos<br>+/–<br>· Sellado de ATB en CVC tunelizados<br>· Retirada del catéter en las situaciones descritas en el texto |\n\npodemos intentar evitar la retirada del catéter asociando a la antibioterapia sistémica un sellado con antibióticos. Consiste, ante la sospecha de bacteriemia asociada a CVC y tras obtener hemocultivos, en dejar en la luz del catéter 1,5 a 3 ml de una solución de antibióticos (por ejemplo, vancomicina 5 mg/ml) que puede mantenerse durante 2-3 días o cambiarse diariamente. En esta situación se suspende la NP por esa vía durante 48-72 horas. Si al reiniciar la NP no se produce una recurrencia de la bacteriemia, se mantiene el tratamiento (sistémico + el sellado) durante dos semanas, evitando así la retirada del catéter. Se optará por pautas antibióticas que se infundan cada 12 o 24 horas; mientras que el sellado se mantendrá durante las horas en las que no se infunde la NP. Si es necesario retirar el CVC, idealmente no se debería insertar uno nuevo hasta que la fiebre haya desaparecido y los hemocultivos de control, extraídos tras retirar el CVC infectado, sean negativos; aunque frecuentemente no es factible esperar tanto tiempo por la dependencia del paciente de la NP71.\n\nEl punto clave en la prevención de las infecciones asociadas a catéter es el cumplimiento de la técnica aséptica en el manejo del catéter, incluyendo el lavado de manos72. En los últimos años se han empleado soluciones de taurolidina y alcohol al 70% para el sellado del CVC en pacientes con NPD y antecedentes de BC como profilaxis secundaria73. Se ha visto que ambos compuestos son efectivos para la prevención de las BC, aunque existen dudas sobre si el uso de etanol se puede asociar con un aumento del riesgo de trombosis74. En el caso de la taurolidina, se recomienda usar los preparados de taurolidina 2% asociada\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}